160 related articles for article (PubMed ID: 3811918)
1. Caryometry of benign compound acquired naevi, Spitz epitheloid naevi and malignant melanomas.
Lindholm C; Hofer PA
Acta Pathol Microbiol Immunol Scand A; 1986 Nov; 94(6):371-4. PubMed ID: 3811918
[TBL] [Abstract][Full Text] [Related]
2. Histological demarcation of lateral borders: an unsupportable criterion for distinguishing malignant melanoma from Spitz naevus and compound naevus.
Okun MR
Histopathology; 1998 Aug; 33(2):158-62. PubMed ID: 9762549
[TBL] [Abstract][Full Text] [Related]
3. Spitz naevi and malignant melanomas of childhood and adolescence.
Peters MS; Goellner JR
Histopathology; 1986 Dec; 10(12):1289-302. PubMed ID: 3817764
[TBL] [Abstract][Full Text] [Related]
4. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
Lindholm C; Bjelkenkrantz K; Hofer PA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
[TBL] [Abstract][Full Text] [Related]
5. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
Rose DS
J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
[TBL] [Abstract][Full Text] [Related]
6. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
[TBL] [Abstract][Full Text] [Related]
7. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of spitzoid tumours: A clinical study.
Hafiji J; Rytina E; Burrows NP
Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697
[TBL] [Abstract][Full Text] [Related]
11. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index.
Schmiegelow P; Schroiff R; Breitbart E; Bahnsen J; Lindner J; Jänner M
Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):47-59. PubMed ID: 3085340
[TBL] [Abstract][Full Text] [Related]
14. Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile.
Orchard DC; Dowling JP; Kelly JW
Australas J Dermatol; 1997 Feb; 38(1):12-4. PubMed ID: 9046646
[TBL] [Abstract][Full Text] [Related]
15. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
17. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
18. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
20. Spitz naevi may express components of the plasminogen activation system.
Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
